Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 10 June 2021

 
 
 
   

19 Conversations | EFPIA's podcast series
 
Podcast: From raw materials to patients’ arms – how are COVID-19 vaccines made?
Today we're asking Luc Van Steenwinkel, Site Lead, Pfizer Puurs and Vice President Pfizer Biotech Operations, and Danny Hendrikse, Vice President, Pfizer Global Supply Chain:

"From raw materials to patients’ arms – how are COVID-19 vaccines made?".

Listen to hear their discussion on the challenge and how we're preparing for the future.

Read more


 
 
 
   

News
 

New ECIPE study on “International EU27 pharmaceutical production, trade, dependencies and vulnerabilities”...
08 June 2021

Faced with the COVID-19 pandemic, global supply chains have shown remarkable resilience, and open markets and open trade... Read more

EFPIA response on the EU Communication on “Urgent Trade Policy Responses to the COVID-19 crisis"...
04 June 2021

Compulsory licensing will not facilitate greater vaccine equity but could put the hard-won progress in fighting this... Read more
 
 
 
   

Events
 

Lessons from the crisis: how a value-based approach can make health systems more resilient
17 June 2021 (Virtual event)

An event by the European Alliance for Value in Health Read more

AMR: how can we prevent the next pandemic?
24 June 2021 (Virtual event)

An EFPIA virtual event Read more

Beating cancer: Looking ahead, learning from the past
25 June 2021 (Virtual event)

The Impact of COVID-19 on Patient Access to Cancer Care in Europe Read more

How can COVID-19 treatments help us on the road to recovery?
29 June 2021 (Virtual event)

An EFPIA virtual event Read more
 
 
 
   

What we are reading
 
« Future4care », the European healthcare startup accelerator launches in Paris
On 10 June 2021 (Future4Care)

Sanofi, Capgemini, Generali and Orange today announced the creation of a joint venture to launch “Future4care”, Europe’s... Read more
EU proposes alternative to IP waiver to expand global vaccine access
On 08 June 2021 (Euractiv)

The EU's multilateral trade action plan is envisaged to expand the production of COVID-19 vaccines and treatments, while... Read more
FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
On 07 June 2021 (STAT)

While other drugs treat symptoms of Alzheimer’s, the new medicine, called Aduhelm, is the first to attack what some... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu
EFPIA 2024 All rights reserved Disclaimer